Context Therapeutics News

Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Avidity Partners Management LP(9.9%),Avidity Partners Management (GP) LLC(9.9%), etc.

May 13 22:39

Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(9.89%),Deep Track Biotechnology Master Fund, Ltd.(9.89%), etc.

May 11 04:07

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Minai-Azary Jennifer Lynn

Mar 22 20:07

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Levit Alex C.

Mar 22 20:07

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lehr Martin A.

Mar 22 20:02

Context Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Affinity Healthcare Fund, LP (EIN(2.06%),Affinity Asset Advisors, LLC (EIN(2.06%)

Feb 14 05:51

Context Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Martin Lehr(8.8%),Martin Lehr 2000 Trust(5.1%), etc.

Feb 8 05:27

Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Opaleye Management Inc.(5.14%)

Jan 5 13:00

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kantoff Philip W.

Jun 1, 2023 04:53

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director West Linda

Jun 1, 2023 04:53

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Stacey Jennifer Evans

Jun 1, 2023 04:53

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BERMAN RICHARD J

Jun 1, 2023 04:52

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities

Feb 22, 2023 09:05

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities

Feb 15, 2023 06:04

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities

Feb 15, 2023 06:04

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities

Feb 15, 2023 06:04

Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Martin Lehr(7.3%),Martin Lehr 2000 Trust(5.1%), etc.

Feb 15, 2023 05:03

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities

Feb 14, 2023 05:03

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities

Feb 7, 2023 05:03

Context Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jan 31, 2023 05:03